CTX IV (6-12), identified by CAS NO.115722-23-1, is a premium-grade stable biomarker fragment generated during the enzymatic degradation of collagen by osteoclast-derived cathepsin K. As a gold-standard reference material, this peptide serves as a critical indicator of active bone resorption rates, making it indispensable for monitoring therapeutic interventions targeting bone loss and analyzing the pathophysiology of various skeletal disorders.
Designed for high-precision academic and pharmaceutical research, CTX IV (6-12) is primarily utilized in the study of osteoporosis, Paget’s disease, and primary hyperparathyroidism. By ensuring exceptional purity and structural consistency, our peptide enables researchers to achieve reproducible quantification of collagen degradation across multiple analytical platforms, facilitating robust clinical research outcomes and accurate fracture risk assessments.
| Product Name | CTX IV (6-12) | CAS NO. | 115722-23-1 |
|---|---|---|---|
| Appearance | White to off-white lyophilized powder | Molecular Formula | C₄₈H₇₀N₁₀O₇ |
| Molecular Weight | 899.14 g/mol | Purity (RP-HPLC) | ≥98.0% |
| Solubility | 1M acetic acid, DMSO, or deionized water | Endotoxin | < 1 EU/mg |
| Storage | -20°C, protected from light/moisture | MOQ | 1 mg |
Maintains ≥98.0% RP-HPLC purity, ensuring minimal interference and high reliability for biomarker validation.
Optimized logistics via DHL, FedEx, and UPS for fast, temperature-controlled international transit.
Defined structure enables precise quantification of collagen breakdown in serum and urine samples.
Produced under strict quality control systems and GMP-compliant production for absolute batch stability.
Each batch includes a COA, HPLC purity report, and MS chromatograms for complete transparency.
Capacity to support diverse needs from milligram-level research to ton-level industrial manufacturing.
Rigorous laboratory testing and validation for every single batch produced.
Advanced peptide synthesis using state-of-the-art automated equipment.
Adherence to international trade standards and pharmaceutical grade certifications.
Strict -20°C climate control to maintain peptide stability and biological activity.
Strategic stock locations in USA, Germany, and China for minimized lead times.
Partnering with renowned universities for continuous biomarker innovation.
| Metric | Standard Grade | GlobalTech Premium |
|---|---|---|
| Purity Level | < 95% | ≥ 98.0% (HPLC) |
| Batch Consistency | Variable | High (Traceable COA) |
| Analytical Error | Moderate | Minimized / Precise |
| Lead Time | 14-21 Days | 3-7 Days (Global Stock) |
| Research Risk | Higher Redo Rate | Optimized Success Rate |
It is used as a gold-standard biomarker to quantify bone resorption rates, primarily for monitoring osteoporosis and the efficacy of anti-resorptive therapies.
The peptide should be stored at -20°C and strictly protected from light and moisture to prevent degradation.
CTX IV (6-12) is soluble in 1M acetic acid, DMSO, or deionized water, depending on your specific assay requirements.
Yes, every batch is accompanied by a Certificate of Analysis (COA), HPLC purity report, and Mass Spectrometry (MS) chromatograms.
Absolutely. We offer professional secure packaging and can customize solutions to meet specific regional or client requirements.
We utilize reliable international air freight partners including DHL, FedEx, UPS, and TNT to ensure speed and temperature integrity.